Repligen Corp [RGEN] stock prices are up 2.98% to $125.94 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RGEN shares have gain 10.73% over the last week, with a monthly amount glided 5.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on September 22, 2025, when Evercore ISI upgraded its rating to a Outperform but kept the price target unchanged to $155 for it. On June 24, 2025, Barclays initiated with a Overweight rating and assigned a price target of $150 on the stock. Wolfe Research upgraded its rating to a Outperform but stick to its price target of $160 on April 29, 2025. Evercore ISI initiated its recommendation with a In-line and recommended $155 as its price target on March 18, 2025. TD Cowen started tracking with a Buy rating for this stock on February 10, 2025, and assigned it a price target of $200. In a note dated December 17, 2024, Canaccord Genuity initiated a Hold rating and provided a target price of $165 on this stock.
The stock price of Repligen Corp [RGEN] has been fluctuating between $102.96 and $182.52 over the past year. Currently, Wall Street analysts expect the stock to reach $205 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $125.94 at the most recent close of the market. An investor can expect a potential return of 62.78% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
The Repligen Corp [NASDAQ:RGEN] reported sales of 673.96M for trailing twelve months, representing a surge of 14.81%. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.02%, and Net Profit Margin reading is -0.02%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 123.82 points at the first support level, and at 121.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 127.88, and for the 2nd resistance point, it is at 129.82.
Ratios To Look Out For
It’s worth pointing out that Repligen Corp [NASDAQ:RGEN]’s Current Ratio is 8.59. In addition, the Quick Ratio stands at 7.32 and the Cash Ratio stands at 5.76. Considering the valuation of this stock, the price to sales ratio is 10.51, the price to book ratio is 3.44.
Transactions by insiders
Recent insider trading involved Hunt Anthony, Director, that happened on Sep 10 ’25 when 29111.0 shares were sold. Director, Hunt Anthony completed a deal on Sep 10 ’25 to buy 29111.0 shares. Meanwhile, Director Madaus Martin D bought 1800.0 shares on Aug 08 ’25.
